Abstract
Embodiments of the invention relate to liposomes comprising: a lipid bilayer having an internal cavity; a therapeutic agent within the internal cavity configured to modify expression or degradation of WASp in a cell; and a targeting moiety external to the lipid bilayer configured to target an extracellular domain of a cell. Embodiments of the invention relate to methods of treatment of disease comprising administering the liposomes. Novel pharmaceutical compositions are also disclosed.
| Original language | American English |
|---|---|
| Pages (from-to) | 962-962 |
| Journal | US Patent App. 10, |
| Volume | 154 |
| State | Published - 28 Oct 2018 |